E-ISSN: 2146-8052
Assessment of a low ankle brachial index in young males with congenital hypogonadism
PDF
Cite
Share
Request
Original Article
VOLUME: 59 ISSUE: 1
P: 11-15
March 2017

Assessment of a low ankle brachial index in young males with congenital hypogonadism

Gulhane Med J 2017;59(1):11-15
DOI: 10.5455/gulhane. 252515
Cem Haymana 1
Aydogan Aydogdu 1
Ilker Tasci 2
Umut Safer 3
Tural Ibrahimov 1
Mustafa Dinc 1
Fatih Yesildal 4
Serkan Tapan 5
Kayıhan Kara 3
Coskun Meric 1
Omer Azal 1
1. Department of Endocrinology and Metabolism, Gulhane Training and Research Hospital, Ankara, Turkey.
2. Department of Internal Medicine, Gulhane Training and Research Hospital, Ankara, Turkey.
3. Haydarpaşa Sultan Abdulhamit Training and Research Hospital, Istanbul, Turkey.
4. Department of Biochemistry, Selahaddin Eyyubi Public Hospital, Diyarbakır, Turkey.
5. Department of Biochemistry, Yuksek Ihtisas University, Ankara, Turkey.
No information available.
No information available
Received Date: 15.12.2016
Accepted Date: 22.03.2017
Publish Date: 30.03.2017
PDF
Cite
Share
Request

ABSTRACT

Cardio-metabolic diseases are prevalent in hypogonadism. Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis and is a well-known predictor of coronary heart disease and stroke. This study investigated whether young and treatment naïve hypogonadal patients had higher frequency of PAD and were under increased risk of systemic atherosclerosis. The study included 49 patients with congenital hypogonadotrophic hypogonadism (CHH) (mean age: 21.82 ± 2.28 years) and 37 healthy control subjects (mean age: 22.34 ± 1.20 years). Blood asymmetric dimethylarginine (ADMA) and high-sensitivity C-reactive protein (hs-CRP) were measured, and insulin resistance was calculated using homeostatic model assessment of insulin resistance (HOMA-IR) score. PAD was determined by the ankle brachial index (ABI) using Doppler technique. Patients with CHH had higher total cholesterol (p=0.038), triglyceride (p=0.047), insulin (p<0.001), HOMA-IR score (p<0.001) and ADMA (p<0.001), and lower body mass index (p=0.001) and systolic blood pressure (p<0.007), compared to healthy controls. Mean ABI value was 1.05 ± 0.13 in patients and 1.00 ± 0.10 in controls (NS). Based on a low ABI, 12.2% of patients and 13.5% of controls had lower extremity PAD (NS). However, in the multivariable model none of the study parameter was a predictor of a low ABI. Young and treatment naive patients with CHH had increased dysmetabolic features such as endothelial dysfunction and insulin resistance but did not have increased frequency of a low ABI compared to controls. ABI measurement might not be a sensitive tool to detect PAD in young male patients with hypogonadism.